Joel I. Berger Joel.Berger@nottingham.ac.uk
Effects of the cannabinoid CB1 agonist ACEA on salicylate ototoxicity, hyperacusis and tinnitus in guinea pigs
Berger, Joel I.; Coomber, Ben; Hill, Samantha; Alexander, Stephen; Owen, William; Palmer, Alan R.; Wallace, Mark N.
Authors
Ben Coomber Ben.Coomber@nottingham.ac.uk
Samantha Hill S.hill@nottingham.ac.uk
STEPHEN ALEXANDER steve.alexander@nottingham.ac.uk
Associate Professor
William Owen
Alan R. Palmer alan.palmer@nottingham.ac.uk
MARK WALLACE mark.wallace@nottingham.ac.uk
Research Fellow
Abstract
Cannabinoids have been suggested as a therapeutic target for a variety of brain disorders. Despite the presence of their receptors throughout the auditory system, little is known about how cannabinoids affect auditory function. We sought to determine whether administration of arachidonyl-2′-chloroethylamide (ACEA), a highly-selective CB1 agonist, could attenuate a variety of auditory effects caused by prior administration of salicylate, and potentially treat tinnitus. We recorded cortical resting-state activity, auditory-evoked cortical activity and auditory brainstem responses (ABRs), from chronically-implanted awake guinea pigs, before and after salicylate + ACEA. Salicylate-induced reductions in click-evoked ABR amplitudes were smaller in the presence of ACEA, suggesting that the ototoxic effects of salicylate were less severe. ACEA also abolished salicylate-induced changes in cortical alpha band (6-10 Hz) oscillatory activity. However, salicylate-induced increases in cortical evoked activity (suggestive of the presence of hyperacusis) were still present with salicylate + ACEA. ACEA administered alone did not induce significant changes in either ABR amplitudes or oscillatory activity, but did increase cortical evoked potentials. Furthermore, in two separate groups of non-implanted animals, we found no evidence that ACEA could reverse behavioural identification of salicylate- or noise-induced tinnitus. Together, these data suggest that while ACEA may be potentially otoprotective, selective CB1 agonists are not effective in diminishing the presence of tinnitus or hyperacusis.
Citation
Berger, J. I., Coomber, B., Hill, S., Alexander, S., Owen, W., Palmer, A. R., & Wallace, M. N. (in press). Effects of the cannabinoid CB1 agonist ACEA on salicylate ototoxicity, hyperacusis and tinnitus in guinea pigs. Hearing Research, https://doi.org/10.1016/j.heares.2017.10.012
Journal Article Type | Article |
---|---|
Acceptance Date | Oct 9, 2017 |
Online Publication Date | Oct 31, 2017 |
Deposit Date | Nov 8, 2017 |
Publicly Available Date | Nov 8, 2017 |
Journal | Hearing Research |
Print ISSN | 0378-5955 |
Electronic ISSN | 1878-5891 |
Publisher | Elsevier |
Peer Reviewed | Peer Reviewed |
DOI | https://doi.org/10.1016/j.heares.2017.10.012 |
Keywords | Tinnitus; cannabinoids; chronic recording; auditory cortex; treatment; salicylate |
Public URL | http://eprints.nottingham.ac.uk/id/eprint/47930 |
Publisher URL | http://www.sciencedirect.com/science/article/pii/S0378595517303593 |
Copyright Statement | Copyright information regarding this work can be found at the following address: http://creativecommons.org/licenses/by/4.0 |
Files
Berger et al. (2017).pdf
(2 Mb)
PDF
Copyright Statement
Copyright information regarding this work can be found at the following address: http://creativecommons.org/licenses/by/4.0
You might also like
Gap-induced inhibition of the post-auricular muscle response in humans and guinea pigs
(2019)
Journal Article
Nitric oxide increases gain in the ventral cochlear nucleus of guinea pigs with tinnitus
(2020)
Journal Article